The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Racial and ethnic disparities in hematologic malignancies
Open accessAbstract
Racial and ethnic disparities in patients with solid malignancies have been well documented. Less is known about these disparities in patients with hematologic malignancies. With the advent of novel chemotherapeutics and targeted molecular, cellular, and immunologic therapies, it is important to identify differences in care that may lead to disparate outcomes. This review provides a critical appraisal of the empirical research on racial and ethnic disparities in incidence, survival, and outcomes in patients with hematologic malignancies. The review focuses on patients with acute myeloid leukemia, acute lymphocytic leukemia, multiple myeloma, non-Hodgkin lymphoma, Hodgkin lymphoma, myeloproliferative neoplasms, and myelodysplastic syndrome. The review discusses possible causes of racial and ethnic disparities and also considers future directions for studies to help decrease disparities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significant racial and ethnic disparities in the incidence and survival of hematologic malignancies have also been documented [51,52].”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Racial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.5.334 · Cited by 953
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemägi, M. C. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 428
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer
Hamel, L., Penner, L., Albrecht, T., Heath, E., Gwede, C., & Eggly, S. (2016) · Cancer Control: Journal of the Moffitt Cancer Cente · doi:10.1177/107327481602300404 · Cited by 426
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Waxman, A. J., Mink, P. J., Devesa, S. S., Anderson, W. F., Weiss, B. M., Kristinsson, S. Y., McGlynn, K. A., & Landgren, O. (2010) · Blood · doi:10.1182/blood-2010-07-298760 · Cited by 411
Cited by
Sorted by citations
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal‐Carmona, L. G., Halmai, N. B., Cruz-Correa, M. R., Davis, M. B., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 952
American Cancer Society nutrition and physical activity guideline for cancer survivors
Rock, C. L., Thomson, C. A., Sullivan, K. R., Howe, C. L., Kushi, L. H., Caan, B. J., Neuhouser, M. L., Bandera, E. V., Wang, Y., Robien, K., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21719 · Cited by 741
Malard, F., Neri, P. E., Bahlis, N. J., Terpos, E., Moukalled, N. M., Hungria, V., Manier, S., & Mohty, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00529-7 · Cited by 387
Epidemiology and Etiology of Leukemia and LymphomaPreprint
Bispo, J. A. B., Pinheiro, P. S., & Kobetz, E. K. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034819 · Cited by 338
Health equity among black women in the United States
Chinn, J. J., Martin, I. K., & Redmond, N. (2021) · Journal of Women's Health · doi:10.1089/jwh.2020.8868 · Cited by 320
Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access
Ahmed, N., Shahzad, M., Shippey, E., Bansal, R., Mushtaq, M. U., Mahmoudjafari, Z., Faisal, M. S., Hoffmann, M. S., Abdallah, A.-O. A., Divine, C. L., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.04.008 · Cited by 146
Du, M., Chen, W., Liu, K., Wang, L., Hu, Y., Mao, Y., Sun, X., Luo, Y., Shi, J., Shao, K., et al. (2022) · Journal of Oncology · doi:10.1155/2022/1612702 · Cited by 117
Fillmore, N. R., Yellapragada, S. V., Ifeorah, C., Mehta, A. K., Cirstea, D. D., White, P. S., Rivero, G., Zimolzak, A. J., Pyarajan, S., Do, N., et al. (2019) · Blood · doi:10.1182/blood.2019000406 · Cited by 107
Bhatnagar, B., Kohlschmidt, J., Mrózek, K., Zhao, Q., Fisher, J. L., Nicolet, D., Walker, C. J., Mims, A. S., Oakes, C. C., Giacopelli, B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1579 · Cited by 85
Muffly, L. S., Alvarez, E. M., Lichtensztajn, D. Y., Abrahão, R., Gomez, S. L., & Keegan, T. H. M. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017014944 · Cited by 79
Barskey, A. E., Derado, G., & Edens, C. (2022) · Emerging infectious diseases · doi:10.3201/eid2803.211435 · Cited by 76
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
Geller, S., Lebowitz, E., Pulitzer, M. P., Horwitz, S. M., Moskowitz, A. J., Dusza, S., & Myskowski, P. L. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.08.073 · Cited by 51
Marcotte, E. L., Domingues, A. M., Sample, J. M., Richardson, M. R., & Spector, L. G. (2021) · Cancer · doi:10.1002/cncr.33678 · Cited by 51
Dong, J., Garacci, E., Buradagunta, C. S., D’Souza, A., Mohan, M., Cunningham, A. M., Janz, S., Dhakal, B., Thrift, A. P., & Hari, P. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00633-5 · Cited by 51
Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials
Duma, N., Azam, T. U., Riaz, I. B., González-Vélez, M., Ailawadhi, S., & Go, R. S. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0592 · Cited by 50
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
Faruqi, A. J., Ligon, J. A., Borgman, P., Steinberg, S. M., Foley, T., Little, L., Mackall, C. L., Lee, D. W., Fry, T. J., Shalabi, H., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007676 · Cited by 48
Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies
Lalaoui, R., Javelle, É., Bakour, S., Úbeda, C., & Rolain, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01422 · Cited by 45
Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival
Stabellini, N., Tomlinson, B. K., Cullen, J., Shanahan, J., Waite, K. A., Montero, A. J., Barnholtz‐Sloan, J. S., & Hamerschlak, N. (2022) · Cancer Medicine · doi:10.1002/cam4.5461 · Cited by 43
Hantel, A., Luskin, M. R., Garcia, J. S., Stock, W., DeAngelo, D. J., & Abel, G. A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005148 · Cited by 41
Piechotta, V., Jakob, T., Langer, P. H., Monsef, I., Scheid, C., Estcourt, L. J., Ocheni, S., Theurich, S., Kuhr, K., Scheckel, B., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013487 · Cited by 35
Kirtane, K., Downey, L., Lee, S. J., Curtis, J. R., & Engelberg, R. A. (2018) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0152 · Cited by 34
Self-citationQayed, M. D., Watkins, B. K., Gillespie, S. E., Bratrude, B., Betz, K., Choi, S. W., Davis, J. H., Duncan, C., Giller, R., Grimley, M. S., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005208 · Cited by 33
Linet, M. S., Curtis, R. E., Schonfeld, S. J., Vo, J. B., Morton, L. M., & Dores, G. M. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102549 · Cited by 32
Cancer in Older Adults: Understanding Cause and Effects of Chemotherapy-Related Toxicities
Bhatt, V. R. (2019) · Future Oncology · doi:10.2217/fon-2019-0159 · Cited by 30
Hall, A. G., Winestone, L. E., Sullivan, E. M., Wu, Q. V., Lamble, A. J., Walters, M. C., Aguayo-Hiraldo, P. I., Baezconde-Garbanati, L. A., Coker, T. R., Dornsife, D. L., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.03.022 · Cited by 30
Stein, E. J., Lenze, N. R., Yarbrough, W. G., Hayes, D. N., Mazul, A. L., & Sheth, S. H. (2020) · Head & Neck · doi:10.1002/hed.26328 · Cited by 27
Casey, M., Odhiambo, L. A., Aggarwal, N., Shoukier, M., Garner, J., Islam, K. M., & Cortes, J. E. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00504 · Cited by 26
Sae-Hau, M., Disare, K., Michaels, M., Gentile, A., Szumita, L., Treiman, K., & Weiss, E. S. (2021) · JCO Oncology Practice · doi:10.1200/op.20.01068 · Cited by 25
Association of serum globulin with all-cause mortality in incident hemodialysis patients
Pai, A. Y., Sy, J., Kim, S. J., Kleine, C., Edward, J. H., Hsiung, J., Kovesdy, C. P., Kalantar‐Zadeh, K., & Streja, E. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab292 · Cited by 23
Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma Incidence
Blansky, D., Mantzaris, I., Rohan, T. E., & Hosgood, H. D. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.05.010 · Cited by 22
Chen, C., Yin, L., Lu, C., Wang, G., Li, Z., Sun, F., Wang, H., Li, C., Dai, S., Lv, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-73617-z · Cited by 22
Bencomo-Alvarez, A. E., Gonzalez, M. A., Rubio, A. J., Olivas, I. M., Lara, J. J., Padilla, O., Orazi, A., Corral, J., Philipovskiy, A. V., Gaur, S., et al. (2020) · Cancer · doi:10.1002/cncr.33347 · Cited by 22
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities
Khera, N., Ailawadhi, S., Brazauskas, R., Patel, J., Jacobs, B., Üstün, C., Ballen, K. K., Abid, M. B., Díaz, M. Á., Al‐Homsi, A. S., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023012469 · Cited by 21
Ansarian, M. A., Fatahichegeni, M., Ren, J., & Wang, X. (2025) · Current Oncology · doi:10.3390/curroncol32040204 · Cited by 20
Smith-Graziani, D. J., & Flowers, C. R. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_320079 · Cited by 20
Addressing racial/ethnic disparities in cancer clinical trials: Everyone has a role to play
Habr, D., & Ferdinand, R. (2021) · Cancer · doi:10.1002/cncr.33600 · Cited by 20
Parsons, M. W., Rock, C. B., Chipman, J., Shah, H., Hu, B., Stephens, D. M., Tao, R., Tward, J. D., & Gaffney, D. K. (2022) · Cancer Medicine · doi:10.1002/cam4.5139 · Cited by 19
Mehta, R. S., Holtan, S. G., Wang, T., Hemmer, M., Spellman, S. R., Arora, M., Couriel, D. R., Alousi, A. M., Pidala, J., Abdel‐Azim, H., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018030171 · Cited by 19
Du, Y., Li, C., & Yan, J. (2023) · Hematology · doi:10.1080/16078454.2023.2198098 · Cited by 18
Jayasekera, J. C., Elkefi, S., Fernandez, J. R., Wojcik, K. M., Woo, J. M. P., Ezeani, A., Ish, J. L., Bhattacharya, M., Ogunsina, K., Chang, C.-J., et al. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad020 · Cited by 17
Langer, S. L., Yi, J. C., Chi, N., & Lindhorst, T. P. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.11.023 · Cited by 18
Dhawan, N., & LeBlanc, T. W. (2021) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091211008431 · Cited by 17
Zha, L., Liu, R., Sobue, T., Kitamura, T., Ishihara, J., Kotemori, A., Ikeda, S., Sawada, N., Iwasaki, M., Tsugane, S., et al. (2021) · Nutrients · doi:10.3390/nu13020590 · Cited by 16
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Wang, X., Gimotty, P. A., Matthews, A. H., Mamtani, R., Luger, S. M., Hexner, E. O., Babushok, D. V., McCurdy, S. R., Frey, N. V., Bruno, X. J., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014127 · Cited by 17
Racial and ethnic disparities among children with primary central nervous system tumors in the US
Nieblas‐Bedolla, E., Christophers, B., Williams, J. R., Power‐Hays, A., Jimenez, N., & Rodriguez, A. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03738-2 · Cited by 15
Varghese, C., Immanuel, T., Ruskova, A., Theakston, E., & Kalev‐Zylinska, M. L. (2021) · Current Oncology · doi:10.3390/curroncol28020146 · Cited by 15
Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy
Lee, J. W., Oh, H., You, J. Y., Lee, E.-S., Lee, J. H., Song, S. E., Lee, N. K., Jung, S. P., An, J. S., Cho, K. R., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.112952 · Cited by 14
Vaughn, J. L., Soroka, O., Epperla, N., Safford, M. M., & Pinheiro, L. C. (2021) · Cancer Medicine · doi:10.1002/cam4.4249 · Cited by 14
Racial disparities, cancer and response to oxidative stress
Zhang, J., Ye, Z., Townsend, D. M., Halbert, C. H., & Tew, K. D. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.012 · Cited by 14
Sociodemographic Disparities in Access to Cleft Rhinoplasty
Phillips, S. J., Hauc, S. C., Sasson, D. C., Khetpal, S., Ihnat, J. M. H., Boroumand, S., Rodriguez, J., Prassinos, A., Lopez, J., & Steinbacher, D. M. (2022) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000008908 · Cited by 13
Garcia, L., Feinglass, J. M., Marfatia, H. A., Adekola, K., & Moreira, J. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01611-8 · Cited by 12
Castañeda‐Avila, M. A., Suárez‐Ramos, T., Torres‐Cintrón, C. R., Epstein, M. M., Gierbolini-Bermúdez, A. J., Tortolero‐Luna, G., & Ortiz‐Ortiz, K. J. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102537 · Cited by 13
Hematopoietic cell transplantation for sickle cell disease: updates and future directions
Krishnamurti, L. (2021) · Hematology · doi:10.1182/hematology.2021000251 · Cited by 13
Montes‐Rodríguez, I. M., Soto‐Salgado, M., Torres‐Cintrón, C. R., Tomassini-Fernandini, J. C., Suarez, E. L., Clavell, L. A., & Cadilla, C. L. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1227 · Cited by 12
Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021
Hu, C., Chen, W., Zhang, P., Shen, T., & Xu, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325937 · Cited by 12
Zheng-Pywell, R., Fang, A., Alkashash, A. M., Awad, S., Reddy, S., Vickers, S. M., Heslin, M. J., Dudeja, V., Chen, H. R., & Rose, J. B. (2021) · Pancreas · doi:10.1097/mpa.0000000000001776 · Cited by 12
Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah
McCarty, R., Trabert, B. L., Kriebel, D., Millar, M. M., Birmann, B. M., Grieshober, L., Barnard, M. E., Collin, L. J., Lawson‐Michod, K. A., Gibson, B., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70260 · Cited by 11
Saadi, M. I., Ramzi, M., Hesami, Z., Kheradmand, N., Owjfard, M., Abdolyousefi, E. N., & Karimi, Z. (2021) · VirusDisease · doi:10.1007/s13337-021-00743-x · Cited by 11
Østgård, L. S. G., Nørgaard, M., Medeiros, B. C., Severinsen, M. T., Friis, L. S., Marcher, C. W., Schöllkopf, C., & Nørgaard, J. M. (2018) · Blood · doi:10.1182/blood-2017-11-814327 · Cited by 11
Vaughn, J. L., Spies, D., Xavier, A. C., & Epperla, N. (2021) · American Journal of Hematology · doi:10.1002/ajh.26198 · Cited by 11
Pediatric AML: state of the Art and Future Directions
Iyer, P. (2025) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2025.2453861 · Cited by 10
Zhou, J., Sweiss, K. I., Nutescu, E. A., Han, J., Patel, P. R., Ko, N. Y., Lee, T. A., Chiu, B. C. ‐., & Calip, G. S. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00479 · Cited by 10
Myelodysplastic syndrome and immunotherapy novel to next in-line treatments
Linder, K. J., & Lulla, P. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1898307 · Cited by 10
Blood cancer health disparities in the United States Hispanic populationPreprint
Bencomo-Alvarez, A. E., Rubio, A. J., Gonzalez, M. A., & Eiring, A. M. (2021) · Molecular Case Studies · doi:10.1101/mcs.a005967 · Cited by 10
Disparities in mortality among acute myeloid leukemia‐related hospitalizations
Alam, S. T., Dongarwar, D., Lopez, E., Yellapragada, S. V., Rivero, G., Huang, Q., Miller-Chism, C. N., Mims, M. P., & Salihu, H. M. (2022) · Cancer Medicine · doi:10.1002/cam4.5084 · Cited by 9
Mikhael, J. R., Sullivan, S. L., Carter, J. D., Heggen, C. L., & Gurska, L. M. (2023) · Current Oncology · doi:10.3390/curroncol30020123 · Cited by 9
Castellanos, M. I., Dongarwar, D., Wanser, R., Caceres, I., Park, C., Rodriguez, J., & Salihu, H. M. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002204 · Cited by 9
Jung, W., Jeon, K. H., Kang, J., Choi, T., Han, K., Jin, S., Jeong, S., & Shin, D. W. (2022) · Biomedicines · doi:10.3390/biomedicines10071617 · Cited by 8
Brunner, A. M., Huggar, D., Copher, R. M., Zhou, Z., Zichlin, M. L., Anderson, A., Downes, N., & McBride, A. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107353 · Cited by 7
A Phase I Trial of Talazoparib in Patients with Advanced Hematologic Malignancies
Gopal, A. K., Popat, R., Mattison, R. J., Menne, T., Bloor, A. J. C., Gaymes, T. J., Khwaja, A., Juckett, M., Chen, Y., Cotter, M. J., et al. (2021) · International Journal of Hematologic Oncology · doi:10.2217/ijh-2021-0004 · Cited by 7
Lesegretain, A., Brunner, A. M., King, A. J., Laadem, A., Fell, G. G., & Fathi, A. T. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.107006 · Cited by 7
Christian, S., Arain, S., Patel, P. R., Khan, I., Calip, G. S., Agrawal, V., Sweiss, K. I., Griffin, S. P., Cahill, K. E., Koenig, H., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25838 · Cited by 7
Chandani, K. U., Agrawal, S. P., Raval, M., Siddiq, S., Nadeem, A., Chintakuntlawar, A. V., & Hashmi, S. K. (2024) · Medicina · doi:10.3390/medicina60050800 · Cited by 6
Loeb, N., Katsnelson, O., Jain, A., Tahvildar, P., Teitelbaum, D. H., & Garcia‐Horton, A. (2025) · Blood Neoplasia · doi:10.1016/j.bneo.2025.100070 · Cited by 6
Survival of U.S. Military Service Members With Lymphoma
Ancira, G. P., Romain, J. T., Pham, K. M., Thornton, J. A., & DeStefano, C. B. (2023) · Military Medicine · doi:10.1093/milmed/usad199 · Cited by 6
Dong, S., Premnath, N., Sadeghi, N., Kainthla, R., Chung, S. S., Collins, R. H., Li, H. C., & Madanat, Y. F. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107503 · Cited by 6
Ibrahim, A. A., Hemida, M. F., Hussein, M., Saghir, M., Faisal, M. R., Kritika, F., Patel, K., Ali, A., Saghir, E., Tablawy, M., et al. (2025) · ASIDE Internal Medicine · doi:10.71079/aside.im.092725233 · Cited by 6
Spiera, Z., Ilonzo, N., Kaplan, H. J., & Leitman, I. M. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108105 · Cited by 6
Bradley, T., Kwon, D., Monge, J., Sekeres, M. A., Chandhok, N. S., Thomassen, A., Swords, R. T., Padron, E., Lancet, J., Talati, C., et al. (2022) · eJHaem · doi:10.1002/jha2.589 · Cited by 6
Mirzazadeh, S., Bemani, P., Halimi, H., Sanaee, M. N., Karami, N., Ramzi, M., & Farjadian, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-38479-x · Cited by 6
Association of killer‐cell immunoglobulin‐like receptor genes with acute myelogenous leukaemia
Alavianmehr, A., Mansouri, M., Ramzi, M., Faghih, M., Monabati, A., Arandi, N., Faghih, Z., & Farjadian, S. (2020) · International Journal of Immunogenetics · doi:10.1111/iji.12509 · Cited by 6
Barakat, M., Albitar, M. X., Whitney, R. L., & Abdulhaq, H. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100310 · Cited by 6
Stem Cell Transplant Experiences Among Hispanic/Latinx Patients: A Qualitative Analysis
Yanez, B. R., Taub, C. J., Waltz, M., Diaz, A., Buitrago, D., Bovbjerg, K., Chicaiza, A., Thompson, R., Rowley, S. D., Moreira, J., et al. (2022) · International Journal of Behavioral Medicine · doi:10.1007/s12529-022-10126-1 · Cited by 7
Analysis of outcomes in hospitalized pregnant patients with acute myeloid leukemia.
Patel, S. J., Ajebo, G. H., Kota, V. K., & Guddati, A. K. (2020) · PubMed Central · Cited by 6
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
Kanamori, T., Sanada, M., Ri, M., Ueno, H., Nishijima, D., Yasuda, T., Tachita, T., Narita, T., Kusumoto, S., Inagaki, A., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16720 · Cited by 5
Ansah, O. O., Daniels-Donkor, S. S., Ledbetter, L., LeBlanc, M. R., & Smith, S. K. (2025) · Palliative & Supportive Care · doi:10.1017/s1478951525000471 · Cited by 5
Mikhael, J. R., Darlington, D., Howell, B., Hydren, J. R., Hernandez, T., Werner, S., Iraca, T., Arnett, M., Gonzalez, V., Peschin, S., et al. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2024.2438561 · Cited by 5
Vaughan, J., Bouwer, N., Willem, P., Wiggill, T. M., & Hodkinson, K. E. (2021) · South African Journal of Oncology · doi:10.4102/sajo.v5i0.179 · Cited by 5
Reimagining diversity in multiple myeloma clinical trials
Habr, D., & Corsaro, M. (2022) · Hematological Oncology · doi:10.1002/hon.2997 · Cited by 5
Gangat, N., Kuykendall, A. T., Ali, N. E. A., Goel, S., Abdelmagid, M. G., Al‐Kali, A., Alkhateeb, H. B., Begna, K. H., Mangaonkar, A. A., Litzow, M. R., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009611 · Cited by 5
Shen, Y.-Z., Chen, F., Yu, J.-W., Zhang, Y., Lu, L.-X., Huo, Y.-L., Chu, S.-T., Cao, B., & Tang, L. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i8.1165 · Cited by 5
Varghese, C., Liu, V. Y., Immanuel, T., Chien, N., Green, T. N., Chan, G. T. C., Theakston, E., & Kalev‐Zylinska, M. L. (2021) · Hematology · doi:10.1080/16078454.2021.1882146 · Cited by 6
Ji, M., Shih, Y.-H., Huber, J. H., Wang, M., Feuer, E. J., Etzioni, R., Wang, S., & Chang, S. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-0490 · Cited by 5
Are we ready for intercultural cancer care?
Crombez, P., Michiels, S., & Bron, D. (2018) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000449 · Cited by 5
Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forward
Contreras, J., Herschbein, L., Mathur, N., & Guzmán, M. L. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102029 · Cited by 4
Reporting of race and ethnicity at an international haematology conference
Mehta, A. K., Fillmore, N. R., Dahiya, S., D’Souza, A., Sweetenham, J. W., & Kansagra, A. J. (2020) · British Journal of Haematology · doi:10.1111/bjh.17065 · Cited by 4
Remote Patient Monitoring: The New Frontier in Telemedicine
Gorbenko, K. O., Kessler, A. J., Liu, M., Besculides, M., Kisswany, C., Mazumdar, M., & Smith, C. B. (2022) · Oncology Issues · doi:10.1080/10463356.2022.2125247 · Cited by 4
Racial/ethnic disparities for leukemias in Puerto Rico and the United States of America, 2015–2019
Ortiz, M. A., Suárez‐Ramos, T., Torres‐Cintrón, C. R., Zegarra, D. Z., Tortolero‐Luna, G., Ortiz‐Ortiz, K. J., & Castañeda‐Avila, M. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285547 · Cited by 4
Epidemiology of Multiple Myeloma
Ríos, R., Rodríguez, D. S., Chang-Chan, D. Y.-L., & Sánchez, M.-J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75396 · Cited by 4
Metadata
- Authors
- Kirtane, K., & Lee, S. J.
- Affiliations
- University of Washington (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-10-12
- Volume
- 130
- Issue
- 15
- Pages
- 1699-1705
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC5639484
- OpenAlex
- W2737749411
- Cited by
- 168
- References
- 52
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 23 · 2023: 24 · 2022: 23 · 2021: 31 · 2020: 16 · 2019: 10 · 2018: 5 · 2017: 1
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- National Institutes of Health
- National Cancer Institute (T32CA009515)
- National Institute on Minority Health and Health Disparities
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- racial and ethnic disparities, hematologic malignancies, acute myeloid leukemia, acute lymphoblastic leukemia, multiple myeloma, non-Hodgkin lymphoma, Hodgkin's disease, myeloproliferative neoplasms, myelodysplastic syndrome, cancer incidence, cancer survival, health disparities
- MeSH terms
- Clinical Trials as Topic, Ethnicity, Humans, Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms, Racial Groups, Health Status Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
